The dominant role of the stromal cell-derived factor 1/C-X-C chemokine receptor type 4 (SDF-1/CXCR4) signaling pathway in promoting breast cancer-associated bone metastasis was described in several studies [40,41]. Here, CXCR4 is linked to breast carcinoma.